Bellini renal cell carcinoma. Diagnosis and treatment.

被引:0
|
作者
Roupret, M [1 ]
Peyromaure, M [1 ]
Hupertan, V [1 ]
Larousserie, F [1 ]
Viellefond, A [1 ]
Thiounn, N [1 ]
Dufour, B [1 ]
Zerbib, M [1 ]
Debre, B [1 ]
Mejean, A [1 ]
机构
[1] GHU Ouest Necker Cochin, APHP, Serv Urol, Paris, France
来源
PROGRES EN UROLOGIE | 2004年 / 14卷 / 04期
关键词
renal cell carcinoma; Bellini collecting duct; metastases; poor prognosis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bellini renal cell carcinoma. Diagnosis and treatment. The Bellini collecting duct carcinoma is a very rare form of renal cell carcinoma (1%). It presents at the stage of metastases in the very great majority of cases. The diagnosis should be considered in patients presenting with marked deterioration of the general status and/or the presence of a very large invasive renal tumour on abdominal CT scan. The overall 2-year survival rate of Bellini carcinoma is about 20%. As the prognosis is very poor, even despite radical nephrectomy, biopsy may be performed as the first-line procedure when the diagnosis is suspected. In the case of primary metastatic Bellini carcinoma, radical nephrectomy alone appears to be useless and dangerous except for analgesic purposes or in the context of new multicentre chemotherapy protocols, combining gemcitabine and cisplatin, currently under evaluation.
引用
收藏
页码:564 / 567
页数:4
相关论文
共 50 条
  • [1] Inhibition of angiogenesis for treatment of renal cell carcinoma.
    Takahashi, A
    Sasamura, H
    Miyao, N
    Yanase, M
    Masumori, N
    Oda, T
    Itoh, N
    Horita, H
    Tsukamoto, T
    JOURNAL OF UROLOGY, 1998, 159 (05): : 168 - 168
  • [2] SBRT versus nephrectomy in the treatment of renal cell carcinoma.
    Patel, Mausam
    Kim, Thomas
    Li, Chenghui
    Safar, Ahmed
    Maraboyina, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Treatment compliance in patients with metastatic renal cell carcinoma.
    Chen, C.
    Hess, G. P.
    Hill, J. W.
    Liu, Z.
    Agarwala, S. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] New treatment approaches for metastatic renal cell carcinoma.
    Nanus D.M.
    Current Oncology Reports, 2000, 2 (5) : 417 - 422
  • [5] Advanced renal cell carcinoma.
    Redman B.G.
    Chang A.E.
    Current Treatment Options in Oncology, 2000, 1 (5) : 417 - 422
  • [6] Dendritic cell vaccine: A potential treatment for metastatic renal cell carcinoma.
    Tanguay, S
    Chagnon, F
    Bergeron, F
    Aprikian, AG
    Gervais, F
    JOURNAL OF UROLOGY, 1998, 159 (05): : 148 - 148
  • [7] Single-fraction radiosurgery for the treatment of renal cell carcinoma.
    Staehler, Michael D.
    Schlenker, Boris
    Karl, Alexander
    Spek, Annabel
    Muacevic, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] Frustration and distress during treatment for advanced renal cell carcinoma.
    Bergerot, Cristiane Decat
    Battle, Dena
    Bergerot, Paulo Gustavo
    George, Daniel J.
    Hammers, Hans J.
    Jonasch, Eric
    Ljungberg, Borje
    Bex, Axel
    Dizman, Nazli
    Staehler, Michael D.
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34)
  • [9] Construction of an immmunohistochemical marker panel for differential diagnosis of renal cell carcinoma.
    Hammerschmied, Christine
    Walter, Bernhard
    Killermann, Martin
    Hofstaedter, Ferdinand
    Junker, Kerstin
    Moch, Holger
    Hartmann, Arndt
    CANCER RESEARCH, 2009, 69
  • [10] Determinants of treatment in patients with stage IV renal cell carcinoma.
    Hollenbeak, Christopher S.
    Schaefer, Eric W.
    Doan, Justin
    Raman, Jay D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)